Reference
Institute for Clinical and Economic Review. ICER Identifies Costliest US Drug-Price Hikes That Are Not Supported by New Clinical Evidence. Internet Document : 8 Oct 2019. Available from: URL: https://icer-review.org/announcements/icer-identifies-costliest-us-drug-price-hikes-that-are-not-supported-by-new-clinical-evidence/
Rights and permissions
About this article
Cite this article
ICER reports hikes in drug prices unsupported by evidence. PharmacoEcon Outcomes News 839, 2 (2019). https://doi.org/10.1007/s40274-019-6283-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6283-x